Market Place
Sourcing Support
Ipsen Announces Beech Tree`s Exemption From Public Tender Offer
03 Apr 2026 //
GLOBENEWSWIRE
Ipsen Reports February 2026 Voting Rights And Share Capital
13 Mar 2026 //
GLOBENEWSWIRE
Ipsen Names Michelle C. Werner EVP, North America President
12 Mar 2026 //
GLOBENEWSWIRE
Ipsen S.A. Publishes Its 2025 Consolidated Financial Statements
19 Feb 2026 //
GLOBENEWSWIRE
Ipsen Reports Strong 2025 Results, Offers 2026 Guidance
12 Feb 2026 //
GLOBENEWSWIRE
Ipsen Reports January 2026 Voting Rights And Share Capital
09 Feb 2026 //
GLOBENEWSWIRE
Ipsen Nominates Peter Guenter To Its Board Of Directors
29 Jan 2026 //
GLOBENEWSWIRE
Pierrick Appoint as Executive Vice President Technical Operations
27 Jan 2026 //
GLOBENEWSWIRE
Galderma Updates Neuromodulator R&D Partnership Arbitration Case
21 Jan 2026 //
BUSINESSWIRE
Ipsen Strengthens Commitment To Neurological Disease Solutions
14 Jan 2026 //
GLOBENEWSWIRE
Ipsen Reports December 2025 Voting Rights And Share Capital
07 Jan 2026 //
GLOBENEWSWIRE
Ipsen Half-Year Statement – 31 December 2025
06 Jan 2026 //
GLOBENEWSWIRE
Ipsen Acquires Imcheck Therapeutics, Expands Oncology Pipeline
15 Dec 2025 //
GLOBENEWSWIRE
Ipsen Buy-Back Programme: Art. 5 MAR - Week 49, 2025
09 Dec 2025 //
GLOBENEWSWIRE
Ipsen Reports November 2025 Voting Rights And Share Capital
08 Dec 2025 //
GLOBENEWSWIRE
Ipsen Provides Update On Legacy Of Henri Beaufour
05 Dec 2025 //
GLOBENEWSWIRE
Ipsen Buy-Back Programme: Art. 5 MAR - Week 48, 2025
02 Dec 2025 //
GLOBENEWSWIRE
Ipsen Mourns Passing Of Founding Family Board Member Henri
01 Dec 2025 //
GLOBENEWSWIRE
Ipsen Share Buyback: MAR Article 5, Week 47 2025
25 Nov 2025 //
GLOBENEWSWIRE
Ipsen Buy-Back Programme: Art. 5 MAR, Week 46 2025
19 Nov 2025 //
GLOBENEWSWIRE
IPSEN - Buy-Back Programme - Art 5 Of MAR - Week 45 - 2025
12 Nov 2025 //
GLOBENEWSWIRE
Ipsen To Present Late-Breaking AASLD Sessions On Iqirvo in PBC
07 Nov 2025 //
GLOBENEWSWIRE
Ipsen Reports October 2025 Voting Rights And Share Capital
07 Nov 2025 //
GLOBENEWSWIRE
IPSEN - Buy-Back Programme - Art 5 Of MAR - Week 44 - 2025
06 Nov 2025 //
GLOBENEWSWIRE
IPSEN - Buy-Back Programme - Art 5 Of MAR - Week 43 - 2025
28 Oct 2025 //
GLOBENEWSWIRE
Ipsen Boosts Full-Year Guidance After Strong 9-Month Sales
22 Oct 2025 //
GLOBENEWSWIRE
IPSEN - Buy-Back Programme - Art 5 Of MAR - Week 42 - 2025
21 Oct 2025 //
GLOBENEWSWIRE
IPSEN - Buy-Back Programme - Art 5 Of MAR - Week 41 - 2025
15 Oct 2025 //
GLOBENEWSWIRE
Ipsen Reports September 2025 Voting Rights And Share Capital
07 Oct 2025 //
GLOBENEWSWIRE
IPSEN - Buy-Back Programme - Art 5 Of MAR - Week 40 - 2025
07 Oct 2025 //
GLOBENEWSWIRE
Ipsen - Buy-Back Programme - Art 5 Of Mar - Week 39 - 2025
30 Sep 2025 //
GLOBENEWSWIRE
Ipsen - Buy-Back Programme - Art 5 of MAR - Week 38 - 2025
23 Sep 2025 //
GLOBENEWSWIRE
Ipsen Advances Ipn10200 To Phase Iii For Aesthetic Use
22 Sep 2025 //
GLOBENEWSWIRE
IPSEN - Buy-Back Program - Art 5 of MAR - Wk 37 - 2025
16 Sep 2025 //
GLOBENEWSWIRE
Ipsen`s August 2025 Report on Voting Rights and Share Capital
11 Sep 2025 //
GLOBENEWSWIRE
IPSEN Initiates Buy-Back Programme - Art 5 of MAR - Week 36, 2025
09 Sep 2025 //
GLOBENEWSWIRE
IPSEN Initiates Buy-back Programme - Art 5 of MAR - Week 35, 2025
02 Sep 2025 //
GLOBENEWSWIRE
IPSEN - Buy-back programme - Art 5 of MAR - Week 34 - 2025
29 Aug 2025 //
GLOBENEWSWIRE
Ipsen Discloses July 2025 Voting Rights and Share Capital
27 Aug 2025 //
GLOBENEWSWIRE
IPSEN Initiates Buy-Back Programme - Art 5 of MAR - Week 33, 2025
19 Aug 2025 //
GLOBENEWSWIRE
IPSEN Initiates Buy-Back Programme - Art 5 of MAR - Week 32, 2025
12 Aug 2025 //
GLOBENEWSWIRE
Ipsen - Buy-Back Programme - Art 5 of Mar - Week 31 - 2025
05 Aug 2025 //
GLOBENEWSWIRE
Ipsen Reports Strong H1 2025 Results, Upgrades Full-Year Guidance
31 Jul 2025 //
GLOBENEWSWIRE
Ipsen S.A. Releases 2025 Half-Year Report
31 Jul 2025 //
GLOBENEWSWIRE
IPSEN Initiates Buy-Back Programme - Art 5 of MAR - Week 30, 2025
29 Jul 2025 //
GLOBENEWSWIRE
Cabometyx® Gets EU Approval for Advanced Neuroendocrine Tumors
24 Jul 2025 //
GLOBENEWSWIRE
Ipsen Reveals Executive Committee Changes
23 Jul 2025 //
GLOBENEWSWIRE
IPSEN Initiates Buy-Back Programme - Art 5 of MAR - Week 29, 2025
22 Jul 2025 //
GLOBENEWSWIRE
IPSEN Initiates Buy-Back Programme - Art 5 of MAR - Week 28, 2025
16 Jul 2025 //
GLOBENEWSWIRE
Ipsen reports voting rights and share capital for June 2025
10 Jul 2025 //
GLOBENEWSWIRE
IPSEN Initiates Buy-Back Programme - Art 5 of MAR - Week 27, 2025
08 Jul 2025 //
GLOBENEWSWIRE
Ipsen - Half Year Statement - 2025 06 30
07 Jul 2025 //
GLOBENEWSWIRE
IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2025
01 Jul 2025 //
GLOBENEWSWIRE
IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2025
24 Jun 2025 //
GLOBENEWSWIRE
Ipsen gets Positive CHMP opinion for Cabometyx in Tumors
20 Jun 2025 //
BUSINESSWIRE
IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2025
17 Jun 2025 //
GLOBENEWSWIRE
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025
13 Jun 2025 //
GLOBENEWSWIRE
Ipsen May 2025 Monthly Voting Rights and Share Capital
12 Jun 2025 //
GLOBENEWSWIRE
Ipsen S.A. - Initiation of Share Buy-Back Program
02 Jun 2025 //
GLOBENEWSWIRE
Genfit to get €26.5M payment for Iqirvo® approval in Italy
20 May 2025 //
GLOBENEWSWIRE
